Provided by Tiger Trade Technology Pte. Ltd.

Mesoblast

17.00
-0.4300-2.47%
Post-market: 17.000.00000.00%19:42 EDT
Volume:164.74K
Turnover:2.80M
Market Cap:2.20B
PE:-23.10
High:17.11
Open:16.98
Low:16.81
Close:17.43
52wk High:21.50
52wk Low:12.66
Shares:129.69M
Float Shares:84.12M
Volume Ratio:0.68
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7359
EPS(LYR):-0.8457
ROE:-18.22%
ROA:-6.16%
PB:3.84
PE(LYR):-20.10

Loading ...

Mesoblast Hits 300‑Patient Milestone in Pivotal Back Pain Trial

TIPRANKS
·
Jul 14

Mesoblast reported Q4 Ryoncil net revenue of $36M

TIPRANKS
·
Jul 13

Mesoblast rises 6.2%

TIPRANKS
·
Jul 13

Mesoblast Reports $36 Million Ryoncil Revenue for Fiscal Q4

MT Newswires Live
·
Jul 10

Mesoblast's Fiscal Fourth Quarter Net Revenue from MSC Therapy Product Sales Beats Jefferies Forecast

MT Newswires Live
·
Jul 10

Mesoblast Says Ryoncil Net Revenue Exceeds Expectations; Shares Up 5%

MT Newswires Live
·
Jul 10

Press Release: Ryoncil(r) Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026

Dow Jones
·
Jul 10

Mesoblast posts US$115m first-year Ryoncil revenue and strengthens capital position

TIPRANKS
·
Jul 10

Mesoblast Ltd - Ryoncil Q4 Net Revenue of Us$36m and Us$115m for Full Year

THOMSON REUTERS
·
Jul 10

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Mesoblast Limited (OtherMEOBF) and Cogstate Ltd (OtherCOGZF)

TIPRANKS
·
Jul 02

Mesoblast Receives Biologics License Application Filing Number From US FDA; Shares Up 3%

MT Newswires Live
·
Jul 01

Mesoblast receives BLA filing number from FDA for rexlemestrocel-L review

TIPRANKS
·
Jul 01

Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs

GlobeNewswire
·
Jul 01

Mesoblast - Requests Modular Review of Bla for Rexlemestrocel-l in End-stage Heart Failure with Lvad

THOMSON REUTERS
·
Jul 01

Mesoblast - Rexlemestrocel-l Receives Orphan Drug and Rmat Designations

THOMSON REUTERS
·
Jul 01

JPMorgan exits substantial holder position in Mesoblast

TIPRANKS
·
Jun 29

Mesoblast Accesses $50 Million Credit Line to Refinance Debt Obligations

MT Newswires Live
·
Jun 25

Mesoblast Draws $50 Million From Facility Provided by Shareholder

MT Newswires Live
·
Jun 25

Press Release: Mesoblast Draws US$50 Million from Five-year Non-dilutive Facility

Dow Jones
·
Jun 25

Mesoblast Taps US$50m Low-Cost Facility to Retire High-Cost Debt and Fund Growth

TIPRANKS
·
Jun 25